Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development.
about
Neuroinflammation in animal models of traumatic brain injury.Protease Activated Receptor 2 (PAR2) Induces Long-Term Depression in the Hippocampus through Transient Receptor Potential Vanilloid 4 (TRPV4)Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injury.Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine
P2860
Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Novel pharmaceutical treatment ...... supporting their development.
@en
Novel pharmaceutical treatment ...... supporting their development.
@nl
type
label
Novel pharmaceutical treatment ...... supporting their development.
@en
Novel pharmaceutical treatment ...... supporting their development.
@nl
prefLabel
Novel pharmaceutical treatment ...... supporting their development.
@en
Novel pharmaceutical treatment ...... supporting their development.
@nl
P2093
P2860
P50
P1476
Novel pharmaceutical treatment ...... supporting their development.
@en
P2093
Chaim G Pick
David Tweedie
Dong Seok Kim
Hanna Deselms
Nigel H Greig
Shaul Schreiber
Vardit Rubovitch
P2860
P356
10.1016/J.JNEUMETH.2016.02.002
P577
2016-02-08T00:00:00Z